Articles from Adverse Event Reporting News (October 22, 2007)

1-22 out of 22 article(s)

Title	Author	Type	Words
Advisory committee to review safety of Tamiflu for children.			235
Advisory panel backs new drug-coated stent.			345
Conferences.			284
Draft guidance issued on adverse event reporting for OTC drugs and dietary supplements.			416
Elan, Biogen say U.S. delays Tysabri drug for Crohn's.		Brief article	175
EMEA recommends withdrawing authorizations for cough medicines with clobutinol.		Brief article	269
FDA advisory committees conclude OTC cold drugs should not be used in children under 6.	Mashaw, Rebecca		1138
FDA announces revisions to labels for ED drugs.			493
FDA commissioner meets with Chinese officials on import safety.		Brief article	162
FDA crackdown on unapproved 'legacy drugs' draws fire.			577
FDA issues alert on Amylin's Byetta as cause of pancreatitis.		Brief article	157
FDA moving forward with plans to launch research center, despite critics.			481
FDA stresses need to vaccinate cochlear implant patients against meningitis.		Brief article	179
Genentech will restrict use of Avastin for eye disease.			716
Lilly's CEO calls for reform of nation's drug safety system.			505
Masoudi named FDA chief counsel.		Brief article	198
Medtronic suspends sale of heart device; FDA issues statement on recall.		Brief article	270
Nevada jury reduces $134.5 million judgment against Wyeth in HRT lawsuit.			514
Revised labels for contrast agents due to deaths.		Brief article	201
Roche, FDA make changes in iPledge program for Accutane.			212
Tests of heart devices to get review.			647
VA limiting use of Avandia.			485